ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
David P. Hartmangruber, Bojan Petrovic
Nuclear Technology | Volume 175 | Number 1 | July 2011 | Pages 187-197
Technical Paper | Special Issue on the 16th Biennial Topical Meeting of the Radiation Protection and Shielding Division / Radiation Transport and Protection | doi.org/10.13182/NT10-165
Articles are hosted by Taylor and Francis Online.
IRIS is an advanced, smaller-power pressurized water reactor, with aggressive dose reduction objectives. Because of its integral configuration, IRIS has a thick downcomer region that significantly reduces the radiation field outside the reactor vessel, forming the technical basis for achieving the objectives. However, this feature also makes the shielding analysis very challenging. The goal of evaluating the dose rate distribution throughout the IRIS nuclear power plant and, in particular, in all accessible areas further amplifies the problem.The MAVRIC sequence of the SCALE6 code system was selected for this analysis. MAVRIC employs a hybrid deterministic-stochastic approach, with CADIS and Forward-CADIS methods being used to develop variance-reduction parameters for Monte Carlo simulations. MAVRIC was successfully applied to determine the dose rate distribution throughout a large portion of the IRIS nuclear power plant including the control room. The obtained results confirmed that the dose rate is below the set target limit in the relevant plant areas and, in particular, in the control room.